Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 36 | 2024 | 306 | 14.410 |
Why?
|
| Asthma | 49 | 2025 | 1051 | 11.770 |
Why?
|
| Nebulizers and Vaporizers | 22 | 2025 | 62 | 6.620 |
Why?
|
| Patient Readmission | 14 | 2024 | 413 | 6.280 |
Why?
|
| Health Literacy | 13 | 2025 | 77 | 5.730 |
Why?
|
| Patient Education as Topic | 16 | 2020 | 378 | 4.330 |
Why?
|
| Metered Dose Inhalers | 13 | 2022 | 33 | 4.090 |
Why?
|
| Hospitalization | 21 | 2024 | 943 | 3.890 |
Why?
|
| Inpatients | 16 | 2024 | 347 | 3.600 |
Why?
|
| Anti-Asthmatic Agents | 12 | 2025 | 93 | 3.530 |
Why?
|
| Patient Care Bundles | 5 | 2023 | 20 | 2.560 |
Why?
|
| Administration, Inhalation | 21 | 2025 | 203 | 2.350 |
Why?
|
| Humans | 127 | 2025 | 96105 | 1.780 |
Why?
|
| School Health Services | 5 | 2019 | 16 | 1.630 |
Why?
|
| Surveys and Questionnaires | 16 | 2025 | 2860 | 1.610 |
Why?
|
| Telemedicine | 6 | 2024 | 229 | 1.570 |
Why?
|
| Inhalation Spacers | 2 | 2021 | 2 | 1.370 |
Why?
|
| Hospital Medicine | 3 | 2025 | 27 | 1.250 |
Why?
|
| Length of Stay | 4 | 2024 | 833 | 1.200 |
Why?
|
| Biomedical Research | 5 | 2025 | 441 | 1.180 |
Why?
|
| Child | 27 | 2025 | 7625 | 1.160 |
Why?
|
| Quality of Health Care | 5 | 2024 | 404 | 1.120 |
Why?
|
| Female | 60 | 2025 | 50028 | 1.100 |
Why?
|
| Male | 57 | 2025 | 45863 | 1.080 |
Why?
|
| Pain Management | 2 | 2025 | 179 | 1.000 |
Why?
|
| Self-Management | 3 | 2024 | 44 | 0.990 |
Why?
|
| Patient Discharge | 4 | 2023 | 361 | 0.980 |
Why?
|
| United States | 23 | 2025 | 7768 | 0.960 |
Why?
|
| Parents | 5 | 2020 | 307 | 0.960 |
Why?
|
| Equipment Failure | 2 | 2020 | 128 | 0.950 |
Why?
|
| Cross-Sectional Studies | 12 | 2025 | 1876 | 0.940 |
Why?
|
| Chicago | 13 | 2025 | 1506 | 0.930 |
Why?
|
| Vision, Low | 2 | 2015 | 15 | 0.930 |
Why?
|
| Child, Hospitalized | 2 | 2023 | 41 | 0.920 |
Why?
|
| Virtual Reality | 1 | 2025 | 39 | 0.880 |
Why?
|
| Vision Disorders | 2 | 2016 | 72 | 0.860 |
Why?
|
| Research Personnel | 2 | 2025 | 84 | 0.850 |
Why?
|
| Adult | 27 | 2025 | 28721 | 0.850 |
Why?
|
| Middle Aged | 30 | 2025 | 28368 | 0.850 |
Why?
|
| Minority Groups | 5 | 2019 | 154 | 0.840 |
Why?
|
| Patient Participation | 3 | 2024 | 242 | 0.830 |
Why?
|
| Research | 1 | 2025 | 265 | 0.820 |
Why?
|
| Health Status Disparities | 2 | 2017 | 221 | 0.820 |
Why?
|
| Attitude of Health Personnel | 3 | 2025 | 682 | 0.810 |
Why?
|
| Hospitals | 4 | 2023 | 329 | 0.810 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2021 | 137 | 0.790 |
Why?
|
| Quality of Life | 9 | 2025 | 1816 | 0.790 |
Why?
|
| Leadership | 1 | 2025 | 159 | 0.790 |
Why?
|
| Anemia, Sickle Cell | 1 | 2025 | 150 | 0.780 |
Why?
|
| Hospitalists | 1 | 2025 | 143 | 0.780 |
Why?
|
| Community Health Workers | 2 | 2022 | 37 | 0.780 |
Why?
|
| Patients | 3 | 2020 | 108 | 0.770 |
Why?
|
| Educational Measurement | 2 | 2016 | 246 | 0.760 |
Why?
|
| Nonprescription Drugs | 1 | 2022 | 18 | 0.750 |
Why?
|
| Education, Medical, Undergraduate | 4 | 2025 | 189 | 0.720 |
Why?
|
| Quality Improvement | 4 | 2020 | 502 | 0.700 |
Why?
|
| Mass Screening | 3 | 2017 | 710 | 0.700 |
Why?
|
| Students, Medical | 5 | 2025 | 455 | 0.690 |
Why?
|
| Women | 1 | 2021 | 26 | 0.670 |
Why?
|
| Physician-Patient Relations | 6 | 2016 | 635 | 0.670 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2025 | 294 | 0.670 |
Why?
|
| Awards and Prizes | 1 | 2021 | 37 | 0.660 |
Why?
|
| Medical Overuse | 1 | 2020 | 40 | 0.650 |
Why?
|
| Drug Misuse | 1 | 2020 | 3 | 0.650 |
Why?
|
| Research Support as Topic | 1 | 2021 | 92 | 0.650 |
Why?
|
| Adolescent | 12 | 2025 | 9895 | 0.640 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 292 | 0.640 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 1230 | 0.640 |
Why?
|
| Emergency Service, Hospital | 6 | 2023 | 594 | 0.630 |
Why?
|
| Deductibles and Coinsurance | 1 | 2020 | 8 | 0.630 |
Why?
|
| Practice Guidelines as Topic | 5 | 2019 | 1096 | 0.620 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 220 | 0.610 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 569 | 0.610 |
Why?
|
| Risk Factors | 8 | 2024 | 5961 | 0.600 |
Why?
|
| Disease Management | 3 | 2020 | 360 | 0.590 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 1979 | 0.590 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 180 | 0.580 |
Why?
|
| Natural Language Processing | 1 | 2019 | 42 | 0.580 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2025 | 75 | 0.560 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 771 | 0.540 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 777 | 0.540 |
Why?
|
| Schools | 2 | 2018 | 84 | 0.540 |
Why?
|
| Aged | 17 | 2025 | 20968 | 0.520 |
Why?
|
| Attitude to Health | 1 | 2018 | 226 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.510 |
Why?
|
| Social Media | 1 | 2019 | 111 | 0.510 |
Why?
|
| Prospective Studies | 11 | 2024 | 4671 | 0.510 |
Why?
|
| Respiratory System Agents | 1 | 2016 | 7 | 0.500 |
Why?
|
| Accidental Falls | 1 | 2016 | 49 | 0.490 |
Why?
|
| Health Policy | 5 | 2018 | 208 | 0.480 |
Why?
|
| Delirium | 2 | 2016 | 79 | 0.480 |
Why?
|
| Point-of-Care Testing | 1 | 2015 | 28 | 0.470 |
Why?
|
| Psychometrics | 2 | 2023 | 340 | 0.470 |
Why?
|
| Data Collection | 3 | 2013 | 381 | 0.470 |
Why?
|
| Spirometry | 4 | 2023 | 78 | 0.460 |
Why?
|
| Disease Progression | 1 | 2020 | 1562 | 0.460 |
Why?
|
| Eyeglasses | 1 | 2015 | 8 | 0.460 |
Why?
|
| Patient Care Team | 2 | 2018 | 307 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 346 | 0.450 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 2 | 2025 | 27 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 334 | 0.450 |
Why?
|
| Retrospective Studies | 8 | 2024 | 10287 | 0.450 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 491 | 0.440 |
Why?
|
| Medicare | 3 | 2024 | 458 | 0.440 |
Why?
|
| Comorbidity | 3 | 2024 | 1011 | 0.430 |
Why?
|
| Patient Advocacy | 1 | 2015 | 65 | 0.430 |
Why?
|
| Pediatrics | 1 | 2019 | 399 | 0.430 |
Why?
|
| Trust | 2 | 2016 | 101 | 0.420 |
Why?
|
| HIV Infections | 1 | 2023 | 974 | 0.410 |
Why?
|
| Guideline Adherence | 4 | 2024 | 245 | 0.400 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 66 | 0.400 |
Why?
|
| Logistic Models | 3 | 2022 | 1268 | 0.390 |
Why?
|
| Heart Failure | 1 | 2023 | 1422 | 0.390 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 110 | 0.380 |
Why?
|
| Internship and Residency | 4 | 2012 | 1134 | 0.380 |
Why?
|
| Formoterol Fumarate | 2 | 2025 | 10 | 0.370 |
Why?
|
| Physicians | 3 | 2020 | 707 | 0.360 |
Why?
|
| Family | 1 | 2013 | 332 | 0.360 |
Why?
|
| Urban Population | 4 | 2018 | 240 | 0.350 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 514 | 0.340 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2025 | 935 | 0.340 |
Why?
|
| Cognition | 1 | 2015 | 635 | 0.340 |
Why?
|
| Schools, Medical | 4 | 2024 | 144 | 0.330 |
Why?
|
| Child, Preschool | 6 | 2023 | 3974 | 0.330 |
Why?
|
| Aging | 1 | 2015 | 766 | 0.330 |
Why?
|
| Minority Health | 1 | 2010 | 10 | 0.330 |
Why?
|
| Societies, Medical | 3 | 2024 | 644 | 0.320 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2024 | 53 | 0.310 |
Why?
|
| Prevalence | 4 | 2024 | 1349 | 0.310 |
Why?
|
| Cost Savings | 2 | 2022 | 71 | 0.310 |
Why?
|
| Chronic Disease | 3 | 2023 | 983 | 0.310 |
Why?
|
| Self Administration | 3 | 2018 | 76 | 0.310 |
Why?
|
| Self Care | 4 | 2016 | 170 | 0.300 |
Why?
|
| Feasibility Studies | 4 | 2020 | 819 | 0.300 |
Why?
|
| Poverty | 3 | 2019 | 196 | 0.300 |
Why?
|
| Teaching | 1 | 2010 | 154 | 0.290 |
Why?
|
| Time Factors | 4 | 2024 | 5580 | 0.280 |
Why?
|
| Patient Outcome Assessment | 3 | 2017 | 87 | 0.280 |
Why?
|
| Educational Status | 2 | 2023 | 202 | 0.280 |
Why?
|
| Qualitative Research | 3 | 2025 | 361 | 0.270 |
Why?
|
| Young Adult | 5 | 2025 | 7025 | 0.270 |
Why?
|
| Sex Factors | 2 | 2024 | 1133 | 0.270 |
Why?
|
| Equipment Design | 2 | 2021 | 427 | 0.270 |
Why?
|
| Comparative Effectiveness Research | 2 | 2020 | 56 | 0.270 |
Why?
|
| Students | 2 | 2018 | 179 | 0.260 |
Why?
|
| Self Concept | 2 | 2019 | 137 | 0.250 |
Why?
|
| Internet | 2 | 2020 | 340 | 0.250 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 640 | 0.250 |
Why?
|
| Registries | 2 | 2024 | 986 | 0.250 |
Why?
|
| Curriculum | 2 | 2024 | 615 | 0.230 |
Why?
|
| Communication Barriers | 2 | 2015 | 32 | 0.230 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 491 | 0.230 |
Why?
|
| Medical History Taking | 1 | 2025 | 88 | 0.220 |
Why?
|
| Muscarinic Antagonists | 1 | 2025 | 61 | 0.220 |
Why?
|
| Program Evaluation | 2 | 2020 | 323 | 0.220 |
Why?
|
| Cost Sharing | 1 | 2024 | 20 | 0.220 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2025 | 123 | 0.210 |
Why?
|
| Electronic Health Records | 3 | 2017 | 372 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2024 | 136 | 0.210 |
Why?
|
| Checklist | 2 | 2016 | 72 | 0.210 |
Why?
|
| Physicians, Primary Care | 1 | 2025 | 110 | 0.210 |
Why?
|
| Control Groups | 1 | 2023 | 16 | 0.200 |
Why?
|
| Diagnosis-Related Groups | 1 | 2023 | 22 | 0.200 |
Why?
|
| Health Promotion | 2 | 2024 | 176 | 0.200 |
Why?
|
| Dry Powder Inhalers | 2 | 2020 | 3 | 0.200 |
Why?
|
| Primary Health Care | 3 | 2025 | 391 | 0.190 |
Why?
|
| Sex Distribution | 2 | 2021 | 175 | 0.190 |
Why?
|
| Chronic Pain | 1 | 2025 | 186 | 0.190 |
Why?
|
| Health Equity | 1 | 2024 | 103 | 0.180 |
Why?
|
| Health Expenditures | 2 | 2024 | 101 | 0.180 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 157 | 0.180 |
Why?
|
| Polysomnography | 1 | 2022 | 155 | 0.180 |
Why?
|
| Aftercare | 1 | 2022 | 90 | 0.180 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 901 | 0.180 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 31 | 0.180 |
Why?
|
| Syndrome | 1 | 2022 | 453 | 0.180 |
Why?
|
| Exercise | 1 | 2024 | 354 | 0.170 |
Why?
|
| Cross Infection | 2 | 2013 | 159 | 0.170 |
Why?
|
| Feedback | 1 | 2021 | 139 | 0.170 |
Why?
|
| Exercise Therapy | 1 | 2021 | 94 | 0.170 |
Why?
|
| Insurance, Health | 2 | 2020 | 182 | 0.170 |
Why?
|
| Physician's Role | 2 | 2013 | 186 | 0.170 |
Why?
|
| Focus Groups | 2 | 2018 | 189 | 0.170 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 3927 | 0.170 |
Why?
|
| Needs Assessment | 2 | 2018 | 171 | 0.160 |
Why?
|
| School Nursing | 1 | 2019 | 3 | 0.150 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 137 | 0.150 |
Why?
|
| Mentors | 2 | 2023 | 101 | 0.150 |
Why?
|
| Machine Learning | 1 | 2022 | 348 | 0.150 |
Why?
|
| Prescription Fees | 1 | 2018 | 10 | 0.150 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 46 | 0.150 |
Why?
|
| Cause of Death | 1 | 2020 | 278 | 0.150 |
Why?
|
| Patient Rights | 1 | 2018 | 16 | 0.140 |
Why?
|
| Research Design | 2 | 2024 | 631 | 0.140 |
Why?
|
| Nurses | 1 | 2018 | 43 | 0.140 |
Why?
|
| Respiration Disorders | 1 | 2018 | 42 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 1010 | 0.140 |
Why?
|
| Pandemics | 2 | 2025 | 880 | 0.140 |
Why?
|
| Congresses as Topic | 1 | 2019 | 125 | 0.140 |
Why?
|
| Allergens | 1 | 2019 | 191 | 0.140 |
Why?
|
| Counseling | 2 | 2010 | 174 | 0.140 |
Why?
|
| Awareness | 1 | 2018 | 90 | 0.140 |
Why?
|
| Health Education | 1 | 2018 | 107 | 0.140 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2017 | 12 | 0.140 |
Why?
|
| Risk Assessment | 4 | 2021 | 2480 | 0.140 |
Why?
|
| Videoconferencing | 1 | 2017 | 20 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 296 | 0.130 |
Why?
|
| Inhalation | 1 | 2017 | 34 | 0.130 |
Why?
|
| Language | 2 | 2015 | 162 | 0.130 |
Why?
|
| Lung | 2 | 2022 | 1384 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 7229 | 0.130 |
Why?
|
| Community Participation | 1 | 2017 | 41 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2880 | 0.130 |
Why?
|
| Videotape Recording | 1 | 2017 | 50 | 0.130 |
Why?
|
| Microcomputers | 1 | 2016 | 26 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 228 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2020 | 1546 | 0.120 |
Why?
|
| Sleep | 2 | 2023 | 458 | 0.120 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 27 | 0.120 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 41 | 0.120 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 91 | 0.120 |
Why?
|
| Bronchodilator Agents | 3 | 2024 | 70 | 0.120 |
Why?
|
| Internal Medicine | 2 | 2010 | 371 | 0.120 |
Why?
|
| Multilingualism | 1 | 2015 | 10 | 0.120 |
Why?
|
| Face | 1 | 2016 | 115 | 0.120 |
Why?
|
| Medicaid | 1 | 2019 | 260 | 0.120 |
Why?
|
| Advisory Committees | 1 | 2016 | 94 | 0.120 |
Why?
|
| Motivation | 1 | 2018 | 310 | 0.120 |
Why?
|
| Problem Solving | 1 | 2015 | 55 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2016 | 108 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1619 | 0.120 |
Why?
|
| Acetates | 1 | 2015 | 69 | 0.120 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 39 | 0.120 |
Why?
|
| Translating | 1 | 2015 | 18 | 0.120 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 66 | 0.120 |
Why?
|
| Androstadienes | 1 | 2015 | 74 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2024 | 3110 | 0.110 |
Why?
|
| Vision Tests | 1 | 2015 | 20 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1176 | 0.110 |
Why?
|
| Quinolines | 1 | 2015 | 89 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 438 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 458 | 0.110 |
Why?
|
| Acute Disease | 1 | 2017 | 872 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2015 | 72 | 0.110 |
Why?
|
| Mobile Applications | 1 | 2016 | 79 | 0.110 |
Why?
|
| Patient Selection | 1 | 2017 | 709 | 0.100 |
Why?
|
| Memory | 1 | 2015 | 229 | 0.100 |
Why?
|
| Software | 1 | 2017 | 698 | 0.100 |
Why?
|
| Drug Therapy, Combination | 2 | 2025 | 813 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 358 | 0.100 |
Why?
|
| Communication | 1 | 2016 | 477 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1179 | 0.090 |
Why?
|
| Interviews as Topic | 2 | 2025 | 376 | 0.080 |
Why?
|
| Cooperative Behavior | 2 | 2023 | 197 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2025 | 9175 | 0.080 |
Why?
|
| Documentation | 2 | 2020 | 103 | 0.060 |
Why?
|
| Muscle Stretching Exercises | 1 | 2024 | 1 | 0.060 |
Why?
|
| Muscle Strength | 1 | 2024 | 38 | 0.050 |
Why?
|
| Caregivers | 2 | 2017 | 185 | 0.050 |
Why?
|
| Medication Therapy Management | 1 | 2024 | 18 | 0.050 |
Why?
|
| Medicare Part C | 1 | 2024 | 7 | 0.050 |
Why?
|
| Postural Balance | 1 | 2024 | 52 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2024 | 61 | 0.050 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 40 | 0.050 |
Why?
|
| Actigraphy | 1 | 2024 | 61 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 938 | 0.050 |
Why?
|
| Walking | 1 | 2024 | 106 | 0.050 |
Why?
|
| Staff Development | 1 | 2023 | 29 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 155 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2023 | 207 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 215 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 513 | 0.040 |
Why?
|
| Sodium | 1 | 2021 | 340 | 0.040 |
Why?
|
| Efficiency | 1 | 2020 | 41 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 376 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 701 | 0.040 |
Why?
|
| Child Welfare | 1 | 2018 | 44 | 0.040 |
Why?
|
| Health Information Exchange | 1 | 2017 | 12 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 286 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 51 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 79 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 626 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 17 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 152 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 136 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2015 | 68 | 0.030 |
Why?
|
| Mental Recall | 1 | 2016 | 173 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 531 | 0.020 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 33 | 0.020 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 24 | 0.020 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2012 | 20 | 0.020 |
Why?
|
| Pressure Ulcer | 1 | 2013 | 44 | 0.020 |
Why?
|
| Sick Leave | 1 | 2012 | 15 | 0.020 |
Why?
|
| Workplace | 1 | 2012 | 33 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2015 | 386 | 0.020 |
Why?
|
| Attention | 1 | 2016 | 413 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2015 | 460 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 2578 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 257 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1715 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 338 | 0.020 |
Why?
|